Regenerative Medical Solutions Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.8M

  • Investors
  • 5

Regenerative Medical Solutions General Information

Description

Operator of a regenerative biotechnology company intended for cellular-level diabetes treatment. The company's platform develops stem cell therapies that transform pluripotent cells into insulin-producing islet cells, avoiding immunosuppressive drugs and embryo-derived materials, enabling healthcare providers and diabetic patients to access a functional, ethical, and potentially curative alternative to insulin injections and organ-dependent transplants.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 505 South Rosa Road
  • Suite 26
  • Madison, WI 53719
  • United States
+1 (312)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 505 South Rosa Road
  • Suite 26
  • Madison, WI 53719
  • United States
+1 (312)

Regenerative Medical Solutions Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Regenerative Medical Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Grant 09-Oct-2025 $1.8M Completed Generating Revenue
8. Later Stage VC 28-Aug-2023 Completed Generating Revenue
7. Grant 23-Sep-2022 Completed Generating Revenue
6. Later Stage VC 14-Aug-2018 Completed Generating Revenue
5. Grant 16-Sep-2016 Completed Generating Revenue
4. Seed Round 07-Nov-2014 Completed Generating Revenue
3. Grant 18-Sep-2014 Completed Generating Revenue
2. Early Stage VC 20-Jun-2013 $850K $1.85M Completed Generating Revenue
1. Capitalization 01-Jan-2012 $1M $1M Completed Startup
To view Regenerative Medical Solutions’s complete valuation and funding history, request access »

Regenerative Medical Solutions Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Regenerative Medical Solutions’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Regenerative Medical Solutions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a regenerative biotechnology company intended for cellular-level diabetes treatment. The company's platform
Biotechnology
Madison, WI

South San Francisco, CA
 

Mont-Saint-Guibert, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Regenerative Medical Solutions Competitors (56)

One of Regenerative Medical Solutions’s 56 competitors is Neurona Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurona Therapeutics Formerly VC-backed South San Francisco, CA
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
Sernova Biotherapeutics Corporation Mississauga, Canada
Histogen Formerly VC-backed San Ramon, CA
Seraxis Venture Capital-Backed Germantown, MD
You’re viewing 5 of 56 competitors. Get the full list »

Regenerative Medical Solutions Patents

Regenerative Medical Solutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160230225-A1 Markers for differentiation of stem cells into differentiated cell populations Active 22-Jan-2015
US-20180080077-A1 Markers for differentiation of stem cells into differentiated cell populations Inactive 22-Jan-2015
US-9828634-B2 Markers for differentiation of stem cells into differentiated cell populations Active 22-Jan-2015
WO-2016118824-A1 Markers for differentiation of stem cells into differentiated cell populations Inactive 22-Jan-2015
US-10138466-B2 Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells Active 19-Sep-2014 C12N5/0676
To view Regenerative Medical Solutions’s complete patent history, request access »

Regenerative Medical Solutions Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Mission Cure Capital Impact Investing Minority
U.S. Department of Health and Human Services Government
National Institute of Diabetes and Digestive and Kidney Diseases Government
Wisconsin Economic Development Government Minority
To view Regenerative Medical Solutions’s complete investors history, request access »

Regenerative Medical Solutions FAQs

  • When was Regenerative Medical Solutions founded?

    Regenerative Medical Solutions was founded in 2012.

  • Where is Regenerative Medical Solutions headquartered?

    Regenerative Medical Solutions is headquartered in Madison, WI.

  • What industry is Regenerative Medical Solutions in?

    Regenerative Medical Solutions’s primary industry is Biotechnology.

  • Is Regenerative Medical Solutions a private or public company?

    Regenerative Medical Solutions is a Private company.

  • What is Regenerative Medical Solutions’s current revenue?

    The current revenue for Regenerative Medical Solutions is .

  • How much funding has Regenerative Medical Solutions raised over time?

    Regenerative Medical Solutions has raised $8.18M.

  • Who are Regenerative Medical Solutions’s investors?

    National Institutes of Health, Mission Cure Capital, U.S. Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, and Wisconsin Economic Development have invested in Regenerative Medical Solutions.

  • Who are Regenerative Medical Solutions’s competitors?

    Neurona Therapeutics, Cellaion, Sernova Biotherapeutics, Histogen, and Seraxis are some of the 56 competitors of Regenerative Medical Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process